Nuclear Medicine Manufacturing Facility - Safety Analysis Report

Australian Nuclear Science and Technology Organisation, a public-sector buyer, is inviting bids for professional engineering services in Australia. Bids close on 3 Dec 2026, 16:00 GMT+11 (in 14 days).

Read the official notice Add to calendar

At a glance

Buyer
Australian Nuclear Science and Technology Organisation (Public sector)
Notice
Invitation to bid
Reference
PSC002821
Category
Professional engineering services
Where
Australia
Published
27 Oct 2026
Closes
3 Dec 2026, 16:00 GMT+11 · in 14 days
How to bid
As the official notice sets out

The buyer's description

Provision of Safety Analysis Report (SAR) consulting services to support regulatory licence applications for ANSTO's Nuc...

From the official notice

Nuclear Medicine Manufacturing Facility - Safety Analysis Report

The Australian Nuclear Science and Technology Organisation (ANSTO) seeks to engage a suitably qualified and experienced consultant to provide Safety Analysis Report (SAR) consulting services for the Nuclear Medicine Manufacturing Facility (NMMF) project at Lucas Heights, NSW. The NMMF will replace ANSTO's existing radiopharmaceutical manufacturing facility and support the long term supply of nuclear medicines for Australia.

The successful consultant will be responsible for developing, coordinating and maintaining the overarching Safety Analysis Report (SAR) and associated Plans and Arrangements (P&A) required to support staged regulatory licence applications to the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA). Services include development of regulatory submission documentation, integration of safety inputs from multiple design consultants and stakeholders, management of review and approval processes, preparation of supporting regulatory forms, and support for ANSTO during licence assessments and approvals.

The consultant will work collaboratively with ANSTO consultants and other project stakeholders to develop a comprehensive safety case for the facility in accordance with applicable ARPANSA regulatory guidance and ANSTO requirements. Detailed scope is outlined in the attached specification.

The services are expected to support multiple licence application packages associated with the design, construction and operation of the NMMF, a nationally significant nuclear medicine manufacturing facility.

1. Tenderer must have been the primary author of a SAR, approved by ARPANSA or an equivalent regulatory authority, on a major project of substantial size, and similar nature within the last five (5) years. Credentials from parties subcontracting to the Tenderer will not be accepted.

2. The Tenderer must not be a joint venture.

3. Complete the Non-disclosure Agreement (NDA) in the form of Offer Schedule 23 Confidentiality Undertaking and return via email to the Contact Officer in accordance with the RFT timetable. The Tenderer must nominate to the Contact Officer a responsible person (email and phone) for distribution of additional information via email.

See indicative timetable in the ATM - Part A

See timeframe for delivery in Part F - Specification

More open tenders from Australian Nuclear Science and Technology Organisation

Similar open tenders

All sections

Edition